AI-generated summary
In this study of APP/PS1 mice, a model of Alzheimer's disease, the authors report that six weeks of 808 nm photobiomodulation improved cognitive deficits and blood-brain barrier integrity and reduced amyloid-beta accumulation, with the effects linked to AMPK pathway activation. Supporting cell experiments used brain endothelial cells treated with LPS. The authors describe the findings as promising, but the abstract does not report a human study.
- Who or what was studied
- Six-month-old female APP/PS1 transgenic mice; bEnd.3 brain microvascular endothelial cells treated in vitro
- Wavelengths
- 808 nm
- Limits stated in the abstract
- Findings come from a mouse model and cell culture experiments, and the abstract does not report human outcomes or the number of animals used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 808 nm
- Power density (irradiance)
- 20 mW/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oxidative stress, Anxiety. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.